Efavirenz Outperforms Boosted Atazanavir among Treatment-Naive HIV-1-Infected Persons in Routine Clinical Care

by Toshibumi Taniguchi MD, Jessica R. Grubb MD, Diana Nurutdinova MD, Nur F. Önen MD, Enbal Shacham PhD, Michael Donovan BS, Edgar Turner Overton MD
Published 2013-03-01